Node-Sparing Short-Course Radiotherapy Plus Chemotherapy, Bevacizumab and PD-1 Inhibitor in Metastatic pMMR/MSS Colorectal Cancer (MODIFI-CRC)

Clinical trial NCT06958419 · RECRUITING

Trial details

NCT number: NCT06958419
Sponsor: Sixth Affiliated Hospital, Sun Yat-sen University
Status: RECRUITING
Phase: Phase 2, Phase 3
Study type: INTERVENTIONAL

Immune Checkpoint Therapy Radiotherapy Metastatic Colorectal Cancer (CRC)

Start date: 2025-05-01
Primary completion: 2030-12-31
Enrollment: 286

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.